BBIO
BridgeBio Pharma Inc
NASDAQ: BBIO · HEALTHCARE · BIOTECHNOLOGY
$70.94
+1.76% today
Updated 2026-04-29
Market cap
$13.75B
P/E ratio
—
P/S ratio
27.39x
EPS (TTM)
$-3.78
Dividend yield
—
52W range
$32 – $85
Volume
2.5M
BridgeBio Pharma Inc (BBIO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $98.04M | $464.94M | $631.68M | $703.59M | $1.01B | $623.04M | $546.38M | $919.34M |
| Cash & equivalents | $92.00M | $436.09M | $363.77M | $356.08M | $393.77M | $376.69M | $375.94M | $681.10M |
| Current assets | $97.13M | $445.22M | $568.62M | $642.82M | $888.86M | $548.85M | $477.59M | $720.69M |
| Total liabilities | $152.73M | $566.44M | $155.70M | $595.70M | $1.88B | $1.87B | $1.89B | $2.38B |
| Current liabilities | $8.55M | $32.58M | $60.38M | $95.65M | $135.07M | $121.43M | $143.84M | $154.40M |
| Long-term debt | — | $54.51M | $91.79M | $475.86M | $1.70B | $1.71B | $1.73B | $1.72B |
| Shareholder equity | $-58.02M | $-163.99M | $408.45M | $57.91M | $-870.41M | $-1.25B | $-1.35B | $-1.47B |
| Retained earnings | $-61.43M | $-170.58M | $-440.03M | $-888.75M | $-1.44B | $-1.92B | $-2.56B | $-3.10B |
| Accounts receivable | — | — | $2.85M | — | $19.75M | $17.08M | $1.75M | $4.72M |
| Inventory | — | — | — | — | $-68.90M | $37.93M | $16.65M | — |
| Goodwill | — | — | — | — | — | — | — | — |